Immediate importance and wider context of cancer control collaborations

Editor's Choice for September 2017

Zirconium vs fluorine for PET imaging

Developing new radiotracers

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Pembrolizumab falls short of endpoints in KEYNOTE 40

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

Chemoradiation remains best treatment for locally advanced cervical cancer

Fertility-preserving procedures in BRCA mutation-positive breast cancer

Biological insight in new drug combinations

BRIM8: Vemurafenib in high risk melanoma patients

Durvalumab in novel combinations for head and neck cancer